Keeping Checkpoint Inhibitors in Check

JAMA Netw Open. 2019 May 3;2(5):e192546. doi: 10.1001/jamanetworkopen.2019.2546.

Authors

Daniel V T Catenacci^{1

2}, Howard Hochster³, Samuel J Klempner⁴

Affiliations

¹ Department of Medicine-Hematology/Oncology, The University of Chicago Medical Center, Chicago, Illinois.
² Associate Editor.
³ Rutgers Cancer Institute of New Jersey, New Brunswick.
⁴ The Angeles Clinic and Research Institute, Los Angeles, California.

PMID: 31050772
DOI: 10.1001/jamanetworkopen.2019.2546

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunotherapy*
Neoplasms*